Klinisk Biokemi i Norden · 1 2015
| 13
Referanser
1. Go AS, Chertow GM, Fan D, McCulloch CE,
Hsu CY. Chronic kidney disease and the
risks of death, cardiovascular events, and
hospitalization. N Engl J Med 2004;351:1296-
305.
2. Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR, White HD, et al. Third
universal definition of myocardial infarc-
tion. Eur Heart J 2012;33:2551-67.
3. Thygesen K, Mair J, Giannitsis E, Mueller C,
Lindahl B, Blankenberg S, et al. How to use
high-sensitivity cardiac troponins in acute
cardiac care. Eur Heart J 2012;33:2252-7.
4. Aakre KM, Rotevatn S, Hagve TA, Bendz B,
Landaas S, Trovik T. [National guidelines for
the interpretation of troponin values in the
diagnosis of acute myocardial infarction].
Tidsskr Nor Laegeforen. 2013;133:E1-6.
5. Jacobs LH, van de Kerkhof J, Mingels AM,
Kleijnen VW, van der Sande FM, Wodzig
WK, et al. Haemodialysis patients longitu-
dinally assessed by highly sensitive cardiac
troponin T and commercial cardiac troponin
T and cardiac troponin I assays. Ann Clin
Biochem. 2009;46(Pt 4):283-90.
6. Aakre KM, Roraas T, Petersen PH, Svarstad
E, Sellevoll H, Skadberg O, et al. Weekly and
90-minute biological variations in cardiac
troponin T and cardiac troponin I in hemo-
dialysis patients and healthy controls. Clin
Chem. 2014;60:838-47.
7. Pfortmueller CA, Lindner G, Leichtle AB,
Fiedler GM, Exadaktylos AK. Diagnostic
significance of high sensitivity troponin in
diagnosis of blunt cardiac injury. Intensive
care medicine. 2014;40:623-4.
8. Artunc F, Mueller C, Breidthardt T, Tweren-
bold R, Peter A, Thamer C, et al. Sensitive tro-
ponins-- which suits better for hemodialysis
patients? Associated factors and prediction
of mortality. PloS one. 2012;7(10):e47610.
PubMed PMID: 23077650.
9. Michos ED, Berger Z, Yeh HC, Suarez-
Cuervo C, Wilson LM, Stacy S, et al. Cardiac
troponins used as diagnostic and prognostic
tests in patients with kidney disease. AHRQ
Comparative Effectiveness Reviews. Rock-
ville (MD)2014.
10. Klinkenberg LJ, van Dijk JW, Tan FE, van
Loon LJ, van Dieijen-Visser MP, Meex
SJ. Circulating cardiac troponin T exhi-
bits a diurnal rhythm. J Am Coll Cardiol
2014;63:1788-95.
11. Sukonthasarn A, Ponglopisit S. Diagnostic
level of cardiac troponin T in patients with
chronic renal dysfunction, a pilot study. J
Med Assoc Thai 2007;90:1749- 58.
12. Austin WJ, Bhalla V, Hernandez-Arce I,
Isakson SR, Beede J, Clopton P, Maisel AS,
Fitzgerald RL. Correlation and prognostic
utility of B-type natriuretic peptide and its
amino-terminal fragment in patients with
chronic kidney disease. Am J Clin Pathol
2006;126:506-12.
13. See comment in PubMed Commons belo-
wAnwaruddin S, Lloyd-Jones DM, Baggish
A, Chen A, Krauser D, Tung R, Chae C,
Januzzi JL Jr. Renal function, congestive
heart failure, and amino-terminal pro-brain
natriuretic peptide measurement: results
from the ProBNP Investigation of Dyspnea in
the Emergency Department (PRIDE) Study.
J Am Coll Cardiol 2006;47:91-7.
14. Aakre KM1, Røraas T, Petersen PH, Svarstad
E, Sæle K, Sandberg S. Week-to-week biologi-
cal variation in the N-terminal prohormone
of brain natriuretic peptide in hemodialysis
patients and healthy individuals. Clin Chem
2013;59:1813-4.
15. Pastural-Thaunat M, Ecochard R, Boumend-
jel N, Abdullah E, Cardozo C, Lenz A, et al.
Relative Change in NT-proBNP Level: An
important risk predictor of cardiovascular
congestion in haemodialysis patients. Neph-
ron Extra 2012;2:311-8.
